Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc. (KRTX) Stock Overview
Explore Karuna Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
12.6B
P/E Ratio
-28.11
EPS (TTM)
$-11.74
ROE
-0.36%
KRTX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Karuna Therapeutics, Inc. (KRTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $477.38.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -28.11 and a market capitalization of 12.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.